Alkermes (NASDAQ:ALKS) PT Raised to $29.00 at Bank of America

Alkermes (NASDAQ:ALKS – Free Report) had its price objective upped by Bank of America from $27.00 to $29.00 in a report released on Tuesday morning, Benzinga reports. Bank of America currently has a neutral rating on the stock. A number of other brokerages have also issued reports on ALKS. Evercore ISI raised Alkermes from an […]

Leave a Reply

Your email address will not be published.

Previous post Wilhelmina International (NASDAQ:WHLM) Receives New Coverage from Analysts at StockNews.com
Next post Ayala Pharmaceuticals (NASDAQ:ADXS) Now Covered by Analysts at StockNews.com